Piclib 125 mg Tablet

Product Description

Piclib 125 mg is a targeted anticancer medication that contains palbociclib, specifically designed for adults diagnosed with hormone receptor-positive (HR+) breast cancer that has metastasized, or spread, to other areas of the body. This medication works by inhibiting specific proteins that promote cancer cell growth, effectively slowing down the progression of the disease. Often used in combination with an aromatase inhibitor as a first-line hormonal treatment or with fulvestrant for patients whose condition has worsened following hormonal therapy, Piclib offers a strategic approach to managing advanced breast cancer. Patients should be aware of potential side effects, including neutropenia, which can increase the risk of infections, necessitating regular blood monitoring during treatment. It is important to follow your healthcare provider's instructions closely while taking this medication. Always consult your doctor before starting Piclib, especially if you have a history of liver problems or are pregnant or breastfeeding. With its innovative formulation, Piclib 125 mg represents a significant advancement in the personalized treatment of metastatic breast cancer.